RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 12-22
  • Valeant hikes its takeover offer for Allergan

    For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts. After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...
  • Valeant again raises bid for Allergan

    Valeant again raises bid for Allergan
    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc.  The revised offer issued Friday now lifts the proposed deal value to about $53 billion, up from Wednesday's bid of...
  • Valeant raises offer for Allergan for 2nd time this week

    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc. The revised offer issued Friday lifts the proposed deal's value to about $53 billion, up from Wednesday's bid of about...
  • Ackman turns up heat on Allergan, calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting nastier. Activist investor Bill Ackman called Monday for a special meeting at which Allergan shareholders could potentially vote out the bulk of the Irvine company's board of directors....
  • Bid for Allergan turns hostile as Ackman calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting downright hostile — and even more bizarre. Activist investor Bill Ackman called for a special meeting at which Allergan shareholders could potentially vote out the bulk of the...
  • Allergan sets shareholder meeting on hostile takeover attempt

    Allergan sets shareholder meeting on hostile takeover attempt
    Allergan Inc. scheduled a Dec. 18 special meeting of its shareholders that could ultimately resolve a hostile takeover attempt by a Canadian rival. Valeant Pharmaceuticals International Inc., which is based near Montreal, has been fighting since April...
  • Investing: The urge to merge is back in a big way

    Every week, it seems, brings news of a corporate coupling (or at least an invitation). Buyouts are brisk in industries ranging from technology to health care, from finance to consumer goods. Halfway through 2014, U.S. companies had announced more than 9,...
  • Allergan fights back: Botox maker reportedly pursuing Salix; stocks up

    Botox maker Allergan Inc. of Irvine is reportedly interested in acquiring a North Carolina drugmaker, part of its effort to fight off a takeover attempt by a Canadian rival. The stock market responded, driving Allergan shares up 4%. Allergan's Tuesday...
  • SEC reviewing attempted takeover of Botox maker Allergan

    The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Ackman's hedge fund, Pershing Square Capital Management,...
  • SEC is investigating bid by Valeant and Bill Ackman for Allergan

    The Securities and Exchange Commission is looking into the way a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Word of the investigation came less than a week after Allergan sued...
  • Ackman, Valeant partnering in bid to acquire Botox maker Allergan

    Activist investor Bill Ackman is partnering with Valeant Pharmaceuticals in an attempt to buy Orange County pharmaceutical company Allergan Inc., which sells the popular wrinkle treatment Botox. Ackman’s Pershing Square Capital Management said...